Investigation of IL-17A Serum Levels in Patients with Nonmelanoma Skin Cancer
Background. Role of interleukin 17A (IL-17A) in carcinogenesis and cancer growth is controversial. Although some researches support its antitumor activity, some others suggest that it promotes the growth and development of different types of cancer including skin cancer by activation of STAT3. Altho...
Saved in:
Main Authors: | Mehdi Ghahartars, Fatemeh Sedaghat, Elham Khajavi, Amir Ali Nejat, Mahyar Malekzadeh, Abbas Ghaderi, Mohammad Javad Fattahi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Dermatology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2021/5540163 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tumor Suppressor Function of CYLD in Nonmelanoma Skin Cancer
by: K. C. Masoumi, et al.
Published: (2011-01-01) -
Teledermatology: From Prevention to Diagnosis of Nonmelanoma and Melanoma Skin Cancer
by: G. Fabbrocini, et al.
Published: (2011-01-01) -
Sentinel Lymph Node Biopsy in Nonmelanoma Skin Cancer Patients
by: Marie-Laure Matthey-Giè, et al.
Published: (2013-01-01) -
Diet and Skin Cancer: The Potential Role of Dietary Antioxidants in Nonmelanoma Skin Cancer Prevention
by: Rajani Katta, et al.
Published: (2015-01-01) -
Density of Langerhans Cells in Nonmelanoma Skin Cancers: A Systematic Review
by: Joanna Pogorzelska-Dyrbuś, et al.
Published: (2020-01-01)